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A B S T R A C T
Providing an accurate prognosis for prolonged disorder of consciousness (pDOC) patients remains a clinical
challenge. Large cross-sectional studies have demonstrated the diagnostic and prognostic value of functional
brain networks measured using high-density electroencephalography (hdEEG). Nonetheless, the prognostic
value of these neural measures has yet to be assessed by longitudinal follow-up. We address this gap by assessing
the utility of hdEEG to prognosticate long-term behavioural outcome, employing longitudinal data collected
from a cohort of patients assessed systematically with resting hdEEG and the Coma Recovery Scale-Revised
(CRS-R) at the bedside over a period of two years. We used canonical correlation analysis to relate clinical
(including CRS-R scores combined with demographic variables) and hdEEG variables to each other. This analysis
revealed that the patient’s age, and the hdEEG theta band power and alpha band connectivity, contributed most
significantly to the relationship between hdEEG and clinical variables. Further, we found that hdEEG measures
recorded at the time of assessment augmented clinical measures in predicting CRS-R scores at the next assess-
ment. Moreover, the rate of hdEEG change not only predicted later changes in CRS-R scores, but also out-
performed clinical measures in terms of prognostic power. Together, these findings suggest that improvements in
functional brain networks precede changes in behavioural awareness in pDOC. We demonstrate here that
bedside hdEEG assessments conducted at specialist nursing homes are feasible, have clinical utility, and can
complement clinical knowledge and systematic behavioural assessments to inform prognosis and care.
1. Introduction
1.1. The prognostic challenge in pDOC
Clinicians face a difficult challenge at predicting the longer-term
outcome of pDOC patients following brain injury. This is in part due to
a lack of studies that have tracked patients systematically to char-
acterise the history of recovery. Longitudinal studies that undertake
systematic follow-up of such patients are challenging as, after acute
care, many patients are transferred to specialist neurological centres,
nursing homes or repatriated to the family home, with incomplete re-
cords of the clinical course and outcomes. As such, most of the studies
of pDOC are cross-sectional with convenience samples of patients that
do not inform the journey of recovery. Clinical practice guidelines
highlight the need for more longitudinal studies to assist with under-
standing long-term recovery following severe brain injury (Physicians
RCo, 2020; Giacino et al., 2018; Royal College of Physicians, 2020).
Recently, we aimed to address this need by conducting a long-
itudinal assessment of 39 pDOC patients to describe the long-term
trajectory of behavioural awareness (Bareham et al., 2019). Patients
were assessed at the bedside with the Coma Recovery Scale-Revised
(CRS-R) once every 3 months for a period of 2 years, allowing for the
assessment of longer-term outcomes. The analysis showed statistically
significant recovery in behaviour recorded by the CRS-R, with im-
provements observed beyond 12 months post injury - supporting the
proposal to abandon diagnoses of permanence (Giacino et al., 2018).
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This finding highlighted that many patients may show evidence of late
behavioural improvements, a pattern in the natural history of recovery
that can be detected with systematic longitudinal follow-up. Also in line
with the update to United States (U.S.) practice guidelines (Giacino
et al., 2018), the study identified that patients’ age, time since injury
and initial CRS-R diagnosis were important predictors of long-term
recovery, highlighting these factors as important for prognostication.
The study also formally assessed, for the first time, the effect of arousal
on CRS-R trajectories (Bareham et al., 2019). Arousal had a significant
effect on the behavioural assessment of awareness and was a significant
predictor of behavioural trajectories.
1.2. Neuroimaging methods to assist prognostication
Recent advances in neuroimaging have indicated that certain neural
correlates are associated with the state of consciousness. In particular,
research with functional Magnetic Resonance Imaging (fMRI) has in-
dicated that default mode network activity is associated with conscious
state in pDOC (Vanhaudenhuyse et al., 2010; Fernández-Espejo et al.,
2012; Demertzi et al., 2015). fMRI has also been the prominent ap-
proach to detect covert awareness in a minority of patients (Owen et al.,
2006; Naci et al., 2014). Problematically, fMRI is unlikely to be viable
as a neuroimaging tool for diagnosis and prognosis as it is often not
available, feasible for the patient, or affordable. Without regular follow
ups to capture variable and delayed changes in behavioural awareness,
the prognostic value of fMRI assessments for pDOC is difficult to de-
termine.
High density electroencephalography (hdEEG) is a technique that
can be used for regular and repeated assessment at the patient’s bed-
side. Resting state functional brain networks measured with hdEEG
have been shown to be associated with behavioural state in pDOC (Sitt
et al., 2014; King et al., 2013; Chennu et al., 2017, 2014). In particular,
structured networks of alpha band connectivity have been shown to
reflect the level of behavioural awareness in both patients (Chennu
et al., 2017, 2014) and in healthy people transitioning in and out of
sedation (Chennu et al., 2016). This hdEEG indicator of consciousness
has also been shown to have prognostic value (Chennu et al., 2017).
This research motivated the prospective BETADOC (Bedside Test of
Awareness in Disorders of Conscious) study, to demonstrate the prog-
nostic utility of this hdEEG measure by longitudinally monitoring in-
dividual patients at the bedside to determine whether accurate esti-
mates of brain network activity can predict behavioural changes. Using
case studies from the BETADOC study, we have already demonstrated
that hdEEG measures can capture the stability and recovery of beha-
vioural awareness over time (Bareham et al., 2018). Moreover, the
hdEEG measures shown to best discriminate between groups of patients
(Chennu et al., 2017) were similarly shown to track the progression
across conscious states within the context of an individual patient.
These promising findings suggest that hdEEG could have clinical value
for prognostication.
1.3. The BETADOC study
With a novel framework that employs a combination of behavioural
and brain-based methods to assess patients’ consciousness state, here
we report findings from one of the first longitudinal multimodal studies
that systematically follows up a group of pDOC patients. Patients were
assessed at the bedside using both the CRS-R and resting state hdEEG
measures once every 3 months for a period of 2 years. In total, we
collected and analysed 185 assessments from 40 patients recruited
across the course of the study.
Firstly, we conducted Canonical Correlation Analysis (CCA) to relate
the hdEEG and clinical measures to each other. This approach allows
for the analysis of the association between two sets of data - the hdEEG
measures that capture the structure of functional brain networks on the
one hand, and clinical (including behavioural and demographic)
measures on the other (Bareham et al., 2019). Previous analysis of these
clinical measures identified arousal as an important predictor of be-
havioural recovery (Bareham et al., 2019). Given that previous research
has identified that these hdEEG measures are closely linked with con-
sciousness state (Chennu et al., 2017), we predicted that arousal will
similarly be an important correlate of the longitudinal trajectory of the
hdEEG measures. Secondly, we used the canonical scores from the CCA,
which independently summarise the pattern of hdEEG and clinical data
over time, to determine whether these measures can be used to prog-
nosticate behavioural changes in awareness.
2. Materials and methods
2.1. Standard protocol Approvals, Registrations, and patient consents
This study was carried out in accordance with the United Kingdom
(UK) National Health Service Research Ethics Committee for
Cambridgeshire (reference: 16/EE/0006) recommendations. Patients'
consultee, or in the absence of a suitable consultee the ward manager
acted as a nominated consultee, provided written informed consent
prior to enrolment in accordance with the UK Mental Capacity Act 2005
and Declaration of Helsinki.
2.2. Patients description
Patients were recruited from and assessed at two specialist neuro-
logical rehabilitation centres, where they received consistent and spe-
cialised care throughout the study. For study inclusion, patients needed
to be aged 16 years or older and clinically diagnosed as pDOC following
any form of sudden onset, non-progressive brain injury. They had to be
referred to, or under review of, a consultant in rehabilitation medicine
or consultant neurologist. Patients were excluded in the instance of
pregnancy, if they were clinically unstable or, if they were diagnosed
with a serious mental health condition prior to their brain injury that
has required active management by a psychiatrist. Patients who
emerged from a DOC immediately prior to recruitment were also ex-
cluded. We retained patients who emerged from pDOC during the
study, although no further assessments were conducted on these pa-
tients after their emergence (see supplementary Table 1). All medica-
tions were recorded at the time of recruitment. Forty patients were
recruited, however one patient died prior to the first scheduled as-
sessment. The analyses presented here are based on the remaining 39
patients (see Fig. 1B). Of these, 16 had an initial CRS-R diagnosis of
UWS, 15 were MCS- (Minimally conscious minus; no evidence of
command following) and 7 MCS+ (Minimally conscious plus; evidence
of command following) and 1 EMCS (Emerged from a minimally con-
scious state). MCS- and MCS + patients were categorised based on the
level of complexity of observed behaviours, consistent with the defi-
nition from Bruno et al. (Bruno et al., 2011). 18 patients had an ae-
tiology of traumatic brain injury (TBI), with the remaining 22 had an
anoxic (14), stroke (5) or other (2) injury. The patients (22 Male, 17
Female) were aged 19–75 years (M = 42.85, SD = 15.75) and were
174–12880 days post ictus (M = 1018.64, SD = 2056.77) at the time
of the first assessment (see Fig. 1B). Over the course of the 2-year data
collection period, 24 patients changed CRS-R diagnosis; 14 progressed
from UWS to MCS-/MCS+/EMCS (N = 1) and 10 from MCS-/+ to
MCS+/EMCS. The patient that initially had a CRS-R diagnosis of EMCS
declined on later assessments to an MCS + diagnosis (see supplemen-
tary Table 1). A subset of data from patients 3, 10, 18 and 21 were
reported in a previous study (Bareham et al., 2018).
2.3. Design
The same researcher (CAB) assessed the patients once every
3 months at the bedside using the CRS-R to determine changes in be-
haviour as well as hdEEG at rest (see Fig. 1A). The CRS-R was
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conducted prior to the hdEEG recording to ensure hdEEG was recorded
at patient’s peak arousal.
2.4. Data availability statement
In total, data from 183 assessments from 39 patients were included
in the analysis and has been made available in the supplementary
material.
Fig. 1
2.5. Coma recovery Scale-Revised
The CRS-R is a 23-item scale behavioural assessment of awareness
for pDOC (Giacino et al., 2004). The scale is split into auditory, visual,
motor, oromotor/verbal, communication, and arousal subscales. Where
possible, the patient was assessed upright in the chair. If this was not
possible, patients were assessed at the bedside with the bed elevated to
an upright sitting position. When it was required, the arousal inter-
vention of applying deep pressure as per the CRS-R guidelines was
administered prior to and, if necessary, throughout the duration of the
examination to ensure the patient maintained peak possible arousal.
2.6. High-density EEG resting state
Fifteen minutes of resting state data was collected using a 128-
channel saline electrode net (Phillips Neuro/Electric Geodesics Inc.)
Data were collected at a sampling rate of 500 Hz and were later down-
sampled to 250 Hz offline. Prior to EEG collection, the CRS-R was ad-
ministered to assist with ensuring patients were awake with their eyes
open. Patients' behaviours and EEG data were monitored online to
ensure recordings were free from seizure activity.
The EEG pre-processing and artifact rejection method was identical
to (Chennu et al., 2017) (see supplementary methods). An average of 15
electrodes were rejected and interpolated (range 1–43). The number of
rejected trials range from 1 to 53 (Mean = 17). ICA was used to remove
muscle artefacts, eyeblinks and in some occasions heartbeat artefacts.
On average, 30 such noisy ICA components were removed (range 2–53).
The data analysis pipeline was identical (Chennu et al., 2017) (see
supplementary methods). Briefly, the debiased weighted phase lag
index (dwPLI) (Vinck et al., 2011) metric of connectivity was estimated
and graph theory metrics were computed to describe the pattern of this
connectivity between electrodes. These measures and the 3D network
topography (see Fig. 1C) were visualised alongside those from controls
and other patient groups in a feedback reports given to family, in ad-
dition to being entered to statistical models. The data analysis pipeline
was implemented using EEGLAB (Delorme and Makeig, 2004), Fieldtrip
(Oostenveld et al., 2011), the Brain Connectivity Toolbox (Rubinov and
Sporns, 2010), and custom MATLAB scripts. The pipeline was auto-
mated except for manual checks for and removal of artifactual chan-
nels, trials and independent components.
2.7. Canonical correlation analysis
Canonical correlation analysis (CCA) seeks maximal correlations
between two sets of data. Drawing on the approach used by (Smith
et al., 2015), we were interested in the correlation between the hdEEG
variables on the one hand, and the clinical variables on the other. The
13 clinical variables were Age, Aetiology, Days since onset of injury,
Gender, Initial Diagnosis (CRS-R diagnosis at the first assessment),
Patient Number and Assessment Number, as well as each of the scores
on the CRS-R subscales.
The hdEEG variables included the mean and standard deviation of
Fig. 1. Study design and data processing pipeline. Fig. 1: A. Illustration of the longitudinal design of the project. Patients were assessed at the bedside every 3-months
with the CRS-R. Data collection began in June 2016 and was completed in June 2018. Patients were recruited at any point in the data collection period up until
February 2018 to obtain a minimum of two assessments. B. Figure illustrating, for each patient, time elapsed since injury onset at the point of recruitment (left),
alongside the timeline of individual assessments and CRS-R diagnoses (right). Patients are ordered by time of recruitment into the study, and those recruited later had
fewer assessments at the end of the 2-year study period. C. Data Processing Pipeline for Connectivity Analysis - Methodology was identical to (Chennu et al., 2017).
Cross-spectral density between pairs of channels was estimated using dwPLI. Resulting connectivity matrices were proportionally thresholded. Thresholded con-
nectivity matrices were visualized as topographs, which combined information about the topography of connectivity with the modular topology of the network.
Graph-theoretic metrics were then calculated after binarising the thresholded connectivity matrices.
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the spectral power, as well as the median and standard deviation (over
the 91 electrodes) of the dwPLI connectivity in the delta, theta and
alpha frequency bands. Additionally, we computed graph-theoretic
variables summarising the connectivity “network”, by thresholding,
binarising and then modelling the 91 × 91 connectivity matrix as
graphs. These graph measures were estimated at each connection
density threshold between 0.1 and 0.9, in steps of 0.025. Briefly, the
clustering coefficient of a network captures its local efficiency (Watts
and Strogatz, 1998), while the characteristic path length measures the
average topological distance between pairs of nodes in a graph, pro-
viding a measure of global efficiency (Watts and Strogatz, 1998).
Modularity, calculated here using the Louvain algorithm (Blondel et al.,
2008), is a network metric that captures the degree to which the nodes
of a network can be parcellated into densely connected, topologically
distinct modules (Fortunato, 2010). Given a modular decomposition,
the participation coefficient of a node is an inter-modular measure of its
centrality. Finally, modular span is average weighted topographical
distance (over the scalp) spanned by a module identified in a network
(Chennu et al., 2014). To combine the graph theory values across
multiple thresholds before entering them into the CCA, Principal
component analysis (PCA) was run over band-wise values at computed
thresholds, and the score of the first component was included, which
explained an average of 72% (SD = 8.7%) of the variance.
In total, we included 42 variables derived from hdEEG, 14 in each of
the 3 frequency bands (see supplementary Table 2 for a full list of
hdEEG variables).
The clinical (N = 13) and EEG (N = 42) datasets were submitted to
CCA using the canoncorr function in MATLAB. The CCA was run with
significance testing estimated non-parametrically, using 2000 rando-
mised permutations of the rows of the behavioural and demographic
variables relative to the hdEEG variables. These permutations, while
destroying the statistical relationship between the variables, respected
the repeated-measures structure of the data and shuffled the order of
the patients while preserving all the assessments from each patient in
the same relative order. The resulting CCA produces a set of canonical
variates that captures the linear combination of variables that produces
the strongest correlation between the two datasets. Each variate has a
score for each patient’s assessment (183 scores per variate).
2.8. Linear Mixed Effects model
To investigative the potential additive prognostic value of the
hdEEG to the clinical measures, we fitted a Linear Mixed Effects Model
(LMEM). Values from the EEG and clinical canonical variates (calcu-
lated by the CCA above) from the previous assessment were entered as
predictors of the current CRS-R score. As described above, the canonical
variate is effectively a weighted mixture of one group of variables that
is maximally correlated with a weighted mixture of another group of
variables. We entered the canonical variate in the LMEM, instead of the
EEG measures themselves, to reduce the dimensionality of the model
and thereby increase sensitivity of the LMEM analysis.
Only patients with at least two clinical and hdEEG assessments
conducted at two separate time points could be included in this analysis
(N = 36 patients, 144 data points). The model included a random
factor of patient number to account for the different number of ob-
servations per patient. The model also included the intercept of time
since the first assessment (assessment number) to account for the
longitudinal nature of the data. The dependent variable of CRS-R score
was normalised using a Gaussian rank inverse normalisation method
(Waerden, 1952) to achieve a Gaussian distribution of values and avoid
any influence of potential outliers. The predictors of clinical and hdEEG
canonical variate (CV) scores from the previous assessment were also
normalised to avoid any influence of outliers. The analysis was con-
ducted using syntax in SPSS software, where the LMEM model equation
was as follows:
= +
+
y
intercept(assessment number) random factor
(patient number) fixed factors(clinical variate, hdEEGvariate)
2.9. Linear stepwise regression
To understand how the rate of change in the hdEEG measures might
predict future change in CRS-R scores, we conducted a linear stepwise
regression on the data from patients that had at least 4 assessments
(N = 23 patients, 46 difference scores). The choice of 4 completed
assessments was motivated by the fact that including patients with 5 or
more assessments reduced the number of patients and statistical power
to a degree that did not allow for formal analysis. We took the rate of
change (Δ) of both the hdEEG and the clinical CV values from
Assessments 1 to 2 and entered these as predictors of the change in
normalised CRS-R scores from Assessments 3 to 4. Using a backward
stepwise methodology, predictors were removed sequentially to gen-
erate the final model that best explained future CRS-R changes.
3. Results
3.1. Correlating hdEEG with clinical progression
CCA was used to investigate the relationship between the EEG and
clinical measures. The first three pairs of canonical variates (CV) were
significantly correlated. However, the first canonical correlation
r = 0.77, p =<0.001 was the strongest and explained the most var-
iance R (Giacino et al., 2018) = 0.033 (see Fig. 2A).
Pearson’s correlations indicated that age was the best predictor of
the EEG CV, followed by Arousal (See Fig. 2B). Notably, age was sig-
nificantly negatively associated with the EEG canonical scores indicating
that high EEG scores were more likely associated with younger patients.
Arousal on the other hand was significantly positively correlated in-
dicating that higher EEG scores was associated with higher arousal
scores on the CRS-R. These findings are in line with the U.S. clinical
practice guidelines (Giacino et al., 2018) and recent findings that age
and arousal subscores were important predictors of CRS-R outcome
(Bareham et al., 2019).
The strongest correlations between the EEG variables and the first
clinical CV were negative correlations with mean and standard devia-
tions of theta power and a positive correlation with clustering and mean
dwPLI connectivity in alpha (see Fig. 2C). This indicates that reductions
in theta power and increases in alpha connectivity best predicted
changes in CRS-R scores over time. This is in line with Bareham et al.
(2018) that demonstrated that dwPLI participation coefficient in the
alpha band tracked improvements in CRS-R for a patient that pro-
gressed from a UWS to MCS- CRS-R diagnosis (Bareham et al., 2018).
3.2. Predicting clinical progression using hdEEG
To understand whether hdEEG had any additive value over and
above the clinical measures at predicting future CRS-R score, we fitted a
Linear Mixed Effects Model (LMEM) to the normalised CRS-R scores
predicted by the clinical and hdEEG CVs from the previous assessment.
This approach enabled us to enter our data into a single statistical
correlation model, without having to resort to pairwise comparisons
and consequent correction for multiple comparisons.
The LMEM indicated that the assessment number (time) and the
EEG CV from the previous assessment were significant predictors of
CRS-R score (see Fig. 3A, Model 1). However, the clinical CV from the
previous assessment was not a significant predictor. We removed this
non-significant predictor and refitted the model (see Fig. 3A, Model 2)
which improved the fit, evidenced by the reduced −2 log likelihood
(see Fig. 3A) indicating the reduced amount of variance left
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Fig. 2. The association between EEG and behaviour over time. Fig. 2: A. Illustration of the correlation between the clinical and EEG variates on the first mode of
variation. Each pair of variates at an assessment is plotted as a blue circle. B. Figure illustrating the correlations between the individual clinical variables and the first
EEG canonical variate. The clinical variables are ordered by the strength of the correlation, from the strongest (top) to the weakest (bottom). Statistically significant
correlations are named and indicated in red. C. Figure illustrating the correlations between the individual EEG variables and the first clinical canonical variate. The
EEG variables are ordered by the strength of the correlation, from the strongest (top) to the weakest (bottom). Significant correlations are represented by the
variables in red coloured text. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3. The value of EEG to predict future CRS-R scores. Fig. 3. The Linear Mixed Effects Models of the CRS-R score predicted by the scores on the EEG and clinical
canonical variates from the previous assessment using backwards stepwise methodology. Non-significant predictors are removed one by one from the model. The
shaded model was the winner, in which a patient’s current CRS-R was predicted only by the previous value of their hdEEG canonical variate. A bar chart of the−2
Log likelihood values is presented for each model. The yellow shaded model 2 had the lowest log likelihood, indicating that it had the relatively lowest amount of
unexplained variance. B. The Linear Mixed Effects Models of the patient’s current CRS-R score predicted by the hdEEG canonical variate and CRS-R score from the
previous assessment using backwards stepwise methodology. The winning model only included the patient’s previous CRS-R score to predict the current one. A bar
chart is presented of the−2 Log likelihood values for each model. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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unexplained. For completeness, we fitted Model 3 to evaluate the pre-
dictive power of the clinical CV alone on future CRS-R scores. The in-
creased −2 Log likelihood confirmed (see Fig. 3A) that removal of the
hdEEG CV reduced predictive power and led to a poorer model fit.
To determine whether the poor predictive power of the clinical CV
was due to its composition of demographic variables with CRS-R sub-
scores, we refitted the LMEM, but this time replacing the clinical CV
with normalised CRS-R scores from the previous assessment instead
(See Fig. 3B). With this model, the hdEEG CV did not explain any
variance over and above the CRS-R score from the previous assessment.
In this case, the best-fitting model (Model 2) included only the As-
sessment Number and the previous CRS-R score, confirmed by com-
parison of the −2 Log likelihoods (see Fig. 3B), with the variance left
unexplained reduced by removal of the hdEEG CV.
3.3. Predicting future changes in CRS-R
A limitation of the modelling above was that predicting the sub-
sequent CRS-R score with the previous CRS-R score may lead to an
improved model fit from identical scaling. As such, the hdEEG CV may
be a poorer predictor simply because the EEG metrics vary on a dif-
ferent scale. To address this, we conducted a subsequent analysis to
investigate the prognostic value of the rate of change (Δ) of the hdEEG
CV and CRS-R scores on future CRS-R changes. By calculating the rate
of change, we put the EEG and normalised CRS-R onto a similar scale,
allowing for a fairer juxtaposition of EEG and clinical measures.
Moreover, this approach investigated whether early changes in hdEEG
predicts later changes in CRS-R scores.
Fig. 4A presents the results of the backwards stepwise linear
regression. The final winning model removed the CRS-R (note the non-
significant t-value of -.856p = 0.402) and instead selected Δ hdEEG CV
from Assessment 1 to 2 as the best predictor of Δ CRS-R from Assess-
ment 3 to 4. The predictive power of this winning model is reflected
with the increased amount of variance explained (Adjusted R2) in
comparison to the model including the Δ Normalised CRS-R score
predictor (see Fig. 4A).
Finally, we found that the Δ hdEEG CV was also a better predictor
than Δ clinical CV (see Fig. 4B; note the t value of −2.982, p = 0.007
for the Δ hdEEG CV whilst Δ clinical CV had a t of only 0.933 and non-
significant p value = 0.362). The linear fit of the Δ hdEEG CV to the Δ
future CRS-R is visualised in Fig. 4C. Whilst the figure demonstrates a
negative correlation between the Δ hdEEG CV and Δ future CRS-R,
likely driven by reductions in theta power (the strongest variable that
correlated with the hdEEG CV), the strength of the correlation is the
most important feature.
3.4. Discussion
The BETADOC study has taken a longitudinal approach to assess
pDOC patients at the bedside in their resident neurological centre using
both behavioural and brain-based methods. This novel framework has
allowed for regular, systematic follow-ups with pDOC patients to assess
the value of both hdEEG and the CRS-R at predicting long-term out-
comes. Our analysis has indicated that the hdEEG measures of theta
power and the connectivity measures of clustering and median dwPLI in
the alpha band are the strongest contributors to the canonical scores of
clinical-behavioural trajectories. Also, patients’ age and arousal levels,
already identified in our previous analysis (Bareham et al., 2019) as
Fig. 4. Changes in EEG measures precede changes in CRS-R scores. Fig. 4. A. Linear Stepwise regression of the change in a patient’s CRS-R scores from assessment 3 to
4 predicted by the change in their hdEEG canonical variate and normalised CRS-R scores in assessments 1 to 2. Models are ordered using backwards stepwise
methodology with non-significant predictors removed sequentially. The winning model, shaded grey, included only the hdEEG variates as predictors. A bar chart of
adjusted R2 values for each model is presented, with the winning model with largest R2 highlighted in yellow. B. Linear stepwise regression of the change in CRS-R
scores from assessment 3 to 4 predicted by the change in hdEEG and clinical canonical variates from assessment 1 to 2. Comparison of this model to the winning
model in panel A shows that this model has less predictive power than the model that includes only the hdEEG canonical variate alone. C. Figure illustrating the
linear relationship between the change in CRS-R scores from assessment 3 to 4 and the change in hdEEG canonical variates from assessment 1 to 2, captured by the
winning model in panel A. Each grey circle is a single patient (N = 23). (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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important predictors of behavioural recovery, were also the strongest
correlates of hdEEG canonical variates. In addition, our findings show
that hdEEG measures, when combined with clinical measures, im-
proved our ability to predict consequent CRS-R scores. Moreover, our
findings show that the rate of hdEEG changes early in the trajectory is
the best predictor of later behavioural changes, outperforming the
predictive power of early behavioural changes. These findings indicate
that resting state hdEEG measures have significant prognostic value for
predicting long-term behavioural outcomes in pDOC.
3.5. The link between brain and behaviour in pDOC recovery
We took a statistically valid approach (CCA) to assess the relation-
ship between patterns of hdEEG and clinical measures over time. This
enabled us to understand how brain and behaviour related to each
other in this complex and variable clinical cohort. In doing so, this
study extends beyond most of previous research that has pinpointed
neural measures most strongly associated with consciousness state
usually measured once in a patient, using a cross-sectional design
(Vanhaudenhuyse et al., 2010; Sitt et al., 2014; King et al., 2013). Here,
over 183 assessments collected systematically from 39 patients every
3 months, we have identified that reductions in theta power and in-
creases in alpha clustering and connectivity are the most important
hdEEG measures that correlate with patients’ clinical profiles. This
finding is consistent with cross-sectional studies showing that reduced
theta power (Chennu et al., 2014) and increases in alpha band con-
nectivity is associated with consciousness state across patient groups
(Sitt et al., 2014; Chennu et al., 2017) and with recovery of individual
cases (Bareham et al., 2018). Therefore, reduced theta band activity
and increased alpha band network connectivity are indicators of higher
consciousness levels, or recovery, in individual patients over time. This
finding has important clinical implications for the development of a
brain-based tool for diagnosis and prognosis. Targeting theta power and
alpha connectivity could improve the sensitivity and accuracy of
methods that aim to measure consciousness and the potential for re-
covery.
The CCA approach also allowed us to assess the clinical measures
most strongly related with hdEEG network changes over time. We
found that along with patients’ age, arousal was an important correlate
of hdEEG. We have previously reported that age and arousal are im-
portant correlates of behavioural recovery (Bareham et al., 2019).
While the role of arousal is clinically known to be important (Giacino
et al., 2004; Wilson et al., 1996; Wannez et al., 2017; Seel et al., 2010),
this is the first time that arousal has been formally tested as an im-
portant correlate of brain-based measures of consciousness.
3.6. Arousal is an important predictor of hdEEG trajectories
Alongside the behavioural assessment of consciousness (Giacino
et al., 2018, 2004), an intervention may be required to ensure peak
arousal before conducting neuroimaging assessments or when using
Brain Computer Interfaces. Also, the influence of arousal is an im-
portant consideration in the development of neuroimaging methods for
diagnosis and prognosis in this patient cohort. Research into compu-
tational methods that aim to produce a valid neural index of con-
sciousness need to appropriately account for fluctuations in arousal that
mediate other neural correlates of consciousness such as connectivity
and complexity.
Consciousness involves an interaction between two theoretical
concepts of arousal and awareness (Laureys, 2005). Whilst arousal is
thought to capture the level of consciousness, awareness is considered to
capture conscious content. Our findings demonstrated that changes in
arousal correlated with changes in hdEEG measures over time. This
finding agrees with the notion that emergence from DOC involves re-
covery of arousal systems that support brain networks that underpin
conscious awareness, perhaps revealing the course of neural
mechanisms in the natural history of recovery following brain injury.
This proposal is in line with the meso-circuit hypothesis (Schiff, 2010),
and could explain the beneficial effects of interventions such as
amantadine and zolpidem (Giacino et al., 2012; Whyte and Myers,
2009; Whyte et al., 2014), and deep brain stimulation (Schiff et al.,
2007), that target regions of the brainstem and thalamus involved in
arousal modulation leading to increases in large scale cortical projec-
tions that support conscious awareness.
3.7. The value of bedside hdEEG to prognosticate behavioural recovery
We directly assessed the prognostic value of the hdEEG measures
combined with some of the clinical measures typically used in current
settings to assist with clinical decisions of prognosis and care plans. The
central finding from our LMEM was that the addition of hdEEG to these
clinical measures improved our ability to predict the CRS-R score in the
next assessment. This finding implicates that hdEEG adds significant
value to prognostication when combined with clinical measures. The
current CRS-R score itself was of course a very good predictor of the
CRS-R score on a subsequent assessment. But this is not entirely sur-
prising given that, in this case, the independent (predictor) variable and
dependent variable are measured on the same scale, whereas the hdEEG
canonical scores have undergone a scale transformation.
To determine whether hdEEG is a valuable inclusion to patient as-
sessments we investigated whether early hdEEG changes predict later
changes in CRS-R scores. This analysis avoided the scaling issue by
keeping all the variables on comparable scales. Our results indicated
that not only did change in the hdEEG CV predict later CRS-R changes,
hdEEG outperformed the prognostic ability of earlier changes in CRS-R
scores. The implication of this finding is that hdEEG would not only be
a valuable contribution to routine clinical care to track changes in
awareness and assist with diagnosis, it would arm clinicians with
stronger evidence to provide accurate prognoses and inform re-
habilitation and care plans.
More generally, this finding also indicates that changes in brain
network measures captured with hdEEG precede changes in behaviour.
This finding has been alluded to in previous cross-sectional studies
using hdEEG (Sitt et al., 2014; Chennu et al., 2017) but not formally
assessed in a longitudinal study until now. Information regarding
changes in brain network connectivity may provide more fine-grained
information regarding the potential for recovery that presages the be-
havioural manifestation of consciousness. As such, hdEEG assessments
are likely to be more valuable than behavioural measures of awareness
to predict behavioural outcomes.
3.8. Clinical utility of bedside hdEEG
The current UK clinical practice guidelines note that resting state
EEG was not considered to have discriminative utility to assist with
diagnosis in pDOC (Physicians RCo, 2020). Since these guidelines have
been published, EEG measures of resting state networks have been
found to capture important information that can discriminate between
diagnostic groups (Chennu et al., 2017, 2014), and these measures have
been shown to be robust enough to significantly predict outcome in
pDOC (Chennu et al., 2017). Here, we have utilised these resting state
hdEEG measures to systematically assess patients at the bedside in their
resident nursing home – an approach that did not require relocation of
patients to a specialised setting. This approach highlights the feasibility
of potentially conducting bedside EEG assessments regularly as part of
routine care to allow for long-term systematic follow up and improved
detection of late changes in awareness.
We showed a strong correlation between hdEEG and clinical mea-
sures of pDOC over time implicating that hdEEG can provide corro-
borative evidence for improved pDOC diagnosis. This could be parti-
cularly useful when behavioural measures are inconsistent due to
arousal fluctuations. Future studies could assess whether sensitivity of
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hdEEG to arousal fluctuations and whether hdEEG variability can pre-
dict CRS-R variability, potentially assisting diagnosis in complex cases.
Moreover, arousal was found to be a significant predictor of both be-
havioural trajectories (Bareham et al., 2019) and hdEEG trajectories in
these patients. It is possible that fine grained, rich, hdEEG measures of
arousal may surpass the CRS-R arousal subscore in terms of prognostic
power. This notion is substantiated by the finding that the rate of
hdEEG change surpassed changes in CRS-R in terms of predicting later
behavioural changes. As such, hdEEG can improve prognostic in-
formation to assist clinical decisions and direct treatment care plans
and allocation of therapeutic resources. From a practical perspective,
high-density EEG saline net takes approximately 10 min to prepare, on
par with low-density EEG systems using conventional gel electrodes.
Hence, hdEEG systems could be feasible for clinical bedside assessments
despite the density of electrodes.
3.9. Limitations
Research has indicated that a minimum of 5 CRS-R assessments are
required to ensure consistency (Wannez et al., 2017). In this study,
patients were assessed only once every 3 months as multiple assess-
ments were not feasible as the scale of this study only allowed for a
single examiner. The arousal sub-scale has been included as a variable
in the study to account for potential fluctuations and the examiner
administered the arousal intervention when considered necessary, as
per CRS-R guidelines (Giacino et al., 2004), to ensure peak arousal prior
to assessment. Nevertheless, the use of a single examiner could have led
to undetected measurement bias. Future larger scale studies should
employ multiple examiners to establish inter-rate reliability between
examiners on longitudinal assessments.
Here, we have used the gaussian normalised CRS-R score as an in-
dicator of behavioural change. However, increases in CRS-R do not
necessarily indicate improved consciousness state (Bodien et al., 2016).
This is accounted for in the CCA with CRS-R diagnosis included as a
variable in the analysis, but this was not able to be included in LMEM
analyses. Nonetheless, the LMEM results still captures whether EEG can
predict behavioural changes as measured by CRS-R.
Due to attrition, and because patients were recruited at any time up
until 3 months before the end of data collection, there are a different
number of assessments for each patient. To control for this potential
source of variation, we included Patient Number as a random factor in
statistical models. The patients reported here all resided in specialist
centres with access to rehabilitation services that other patients may
not have access to. To better characterise the role of the rehabilitation
context on patient trajectories, further larger studies could involve
patients from multiple centres.
3.10. Conclusions
The strength of the longitudinal design in the BETADOC study has
revealed important predictors of longer-term outcomes in pDOC. Using
CCA, we identified the hdEEG measures most strongly linked with be-
havioural and demographic variables. The prognostic value of the
hdEEG measures was evident when combined with clinical measures.
Moreover, the utility of early hdEEG changes surpassed early beha-
vioural changes in prognosticating later changes in behaviour. The
addition of regular and repeated hdEEG to routine care then, will not
just benefit current clinical assessments by providing corroborative
evidence. Our findings here indicate that hdEEG assessments can fur-
ther improve the accuracy of clinical prognostication. Crucially, hdEEG
measures captured patients’ potential for recovery with changes in
hdEEG preceding behavioural changes. Finally, we note that arousal
was also an important correlate of hdEEG measures and, as such,
arousal levels should be taken into account during diagnostic and
prognostic neuroimaging in pDOC.
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